The Stanford Neuro-Oncology Program Adult Clinical Trials

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PI: Lawrence Recht #: NCT01480479

MEDI 3617: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
PI: Lawrence Recht #: NCT01248949

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PI: Gordon Li #: NCT01498328

PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PI: Scott Soltys NCT01120639

A Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
PI: Scott Soltys NCT00928226

18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PI: Sanjiv Sam Gambhir NCT01806675

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
PI: Sanjiv Sam Gambhir NCT00185848

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PI: Lawrence Recht NCT01977677

MEDI4736: A Phase 1/2 Study to Evaluate MEDI4736
PI: Heather Wakelee NCT01693562

NKTR-102: Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PI: Lawrence Recht NCT01663012

A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy (CheckMate 204)
PI: Reena Thomas NCT02320058